Peijia Medical Limited (HKG:9996)
6.13
+0.21 (3.55%)
At close: Mar 27, 2026
Peijia Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 536.73 | 666.74 | 795.77 | 1,670 | 2,296 |
Short-Term Investments | 29.96 | 31.04 | 70 | 1.87 | 1.93 |
Trading Asset Securities | - | 14.75 | 77.16 | 71.56 | - |
Cash & Short-Term Investments | 566.7 | 712.52 | 942.93 | 1,743 | 2,298 |
Cash Growth | -20.47% | -24.44% | -45.91% | -24.15% | -6.72% |
Accounts Receivable | 15.28 | 101.04 | 80.21 | 12.6 | - |
Other Receivables | 21.04 | - | - | 63.26 | 31.41 |
Receivables | 39.76 | 101.04 | 80.21 | 75.86 | 31.41 |
Inventory | 153.52 | 156.8 | 170.65 | 173.19 | 85.97 |
Restricted Cash | 50 | - | - | - | - |
Other Current Assets | 11.82 | 16.64 | 43.71 | 15.3 | 10.95 |
Total Current Assets | 821.79 | 987 | 1,237 | 2,007 | 2,426 |
Property, Plant & Equipment | 757.42 | 695.76 | 498.61 | 327.44 | 176.22 |
Long-Term Investments | 337.28 | 326.81 | 387.06 | 415.49 | 224.42 |
Goodwill | - | 51.66 | 51.66 | 51.66 | 51.66 |
Other Intangible Assets | 731.42 | 604.34 | 476.22 | 487.29 | 224.84 |
Other Long-Term Assets | 2 | 23.14 | 20.94 | 13.33 | 60.16 |
Total Assets | 2,657 | 2,689 | 2,672 | 3,316 | 3,164 |
Accounts Payable | 68.14 | 25.72 | 19.71 | 361.58 | 54.17 |
Accrued Expenses | 74.42 | 50.65 | 53 | 50.48 | 24.49 |
Short-Term Debt | 390.66 | 89.78 | 13.83 | 56.06 | - |
Current Portion of Leases | 2.69 | 2.09 | 2.59 | 2.89 | 3.55 |
Current Income Taxes Payable | - | 1.27 | - | 15.27 | 5.39 |
Other Current Liabilities | 142.81 | 273.19 | 65.12 | 91.75 | 31.12 |
Total Current Liabilities | 678.73 | 442.7 | 154.25 | 578.02 | 118.71 |
Long-Term Debt | 37.98 | 158.31 | 203.59 | 70.77 | - |
Long-Term Leases | 2.7 | 3.22 | 1.13 | 2.15 | 4.08 |
Long-Term Unearned Revenue | 20.11 | 20.77 | 13.1 | 1.72 | 1.37 |
Long-Term Deferred Tax Liabilities | 16.49 | 16.78 | 20.32 | 20.32 | 20.32 |
Other Long-Term Liabilities | 42.7 | 2.32 | 5.49 | 5.87 | - |
Total Liabilities | 798.71 | 644.11 | 397.88 | 678.86 | 144.48 |
Common Stock | 6,332 | 0.47 | 0.48 | 0.48 | 0.47 |
Additional Paid-In Capital | - | 6,323 | 6,359 | 6,369 | 6,339 |
Retained Earnings | - | - | - | -3,713 | -3,305 |
Treasury Stock | - | - | - | -82.74 | -84.55 |
Comprehensive Income & Other | -4,488 | -4,296 | -4,085 | 63.62 | 69.14 |
Total Common Equity | 1,844 | 2,028 | 2,274 | 2,638 | 3,019 |
Minority Interest | 13.61 | 16.56 | -0.03 | - | - |
Shareholders' Equity | 1,858 | 2,045 | 2,274 | 2,638 | 3,019 |
Total Liabilities & Equity | 2,657 | 2,689 | 2,672 | 3,316 | 3,164 |
Total Debt | 434.03 | 253.4 | 221.14 | 131.88 | 7.63 |
Net Cash (Debt) | 132.66 | 459.12 | 721.79 | 1,611 | 2,290 |
Net Cash Growth | -71.11% | -36.39% | -55.20% | -29.65% | -6.68% |
Net Cash Per Share | 0.20 | 0.69 | 1.06 | 2.39 | 3.46 |
Filing Date Shares Outstanding | 664.48 | 665.19 | 675.51 | 672.2 | 666.69 |
Total Common Shares Outstanding | 664.48 | 665.19 | 675.51 | 672.2 | 666.69 |
Working Capital | 143.06 | 544.3 | 1,083 | 1,429 | 2,308 |
Book Value Per Share | 2.78 | 3.05 | 3.37 | 3.92 | 4.53 |
Tangible Book Value | 1,113 | 1,372 | 1,746 | 2,099 | 2,743 |
Tangible Book Value Per Share | 1.68 | 2.06 | 2.59 | 3.12 | 4.11 |
Buildings | - | 433.17 | 61.97 | 53.56 | 53.53 |
Machinery | - | 184.28 | 152.79 | 109.64 | 76.51 |
Construction In Progress | - | 122.31 | 290.45 | 167.41 | 28.61 |
Leasehold Improvements | - | 40.72 | 39.11 | 38.6 | 31.06 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.